On Wednesday, Abbott Laboratories stated that it received the marketing permission from that the U.S. Food and Drug Administration (FDA) that has announced Emergency Use Authorization (EUA) for its BinaxNOW COVID-19 Ag Card rapid test. The compact antigen analysis can give results in 15 minutes and will sell it for an affordable rate that is $5.
The test is highly portable that is of the size of a credit card. It is affordable and gives results in 15 minutes. Abbott anticipates exporting millions of tests by September, reaching 50 million tests a month from the start of October. BinaxNOW COVID-19 Ag Card could is to verify that people involving in larger bodies, like schools or workplaces.
Abbott created an app that people taken the test can enter that they are COVID-19 free.
They are to offer a no-charge complimentary phone app named NAVICA for iPhone and Android devices, it enables people to see their BinaxNOW test results when required by organizations in regions where people gather, like workplaces and schools and any other public places.
“We intentionally designed the BinaxNOW test and NAVICA app so we could offer a comprehensive testing solution to help Americans feel more confident about their health and lives,” stated Robert B. Ford, president and chief executive officer, Abbott in a press release.
“BinaxNOW and the NAVICA app give us an affordable, easy-to-use, scalable test, and a complimentary digital health tool to help us have a bit more normalcy in our daily lives,” he added.
Abbott has produced more than 27 million COVID-19 tests in the U.S., along with 14 million detection and 13 million antibody tests.
If the test is negative, the app will present a digital health pass through a QR code, related to an airline boarding pass.
If test outcomes are positive, people get a message to quarantine and talk to the doctor. The digital health pass is found in the app temporarily and stops following the period defined by organizations that allow the app.
The antigen tests are more affordable and quicker than any other diagnostic tests but moderately more prone to fail to recognise positive cases of the virus.
The company got U.S. authorisations since March along with five other coronavirus tests, along with ID Now that can give results within minutes and that is been used at the White House.
Abbott is a worldwide healthcare system with leading firms and products like medical devices, nutritional and branded generic medicines. The company serve in more than 160 countries.